Is Neogen Stock a Good Investment?
Neogen Investment Advice | NEOG |
- Examine Neogen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Neogen's leadership team and their track record. Good management can help Neogen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Neogen's business and its evolving consumer preferences.
- Compare Neogen's performance and market position to its competitors. Analyze how Neogen is positioned in terms of product offerings, innovation, and market share.
- Check if Neogen pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Neogen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Neogen stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Neogen is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Soft | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Small | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Neogen Stock
Researching Neogen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neogen has Price/Earnings To Growth (PEG) ratio of 0.66. The entity recorded a loss per share of 4.8. The firm had not issued any dividends in recent years. Neogen had 2:1 split on the 7th of June 2021.
To determine if Neogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Neogen's research are outlined below:
| Neogen had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 894.66 M. Net Loss for the year was (1.09 B) with profit before overhead, payroll, taxes, and interest of 411.42 M. | |
| Over 99.0% of the company shares are owned by institutional investors |
Neogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Neogen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 25th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Neogen's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.3 B.Neogen's profitablity analysis
The company has Profit Margin (PM) of (1.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08.Determining Neogen's profitability involves analyzing its financial statements and using various financial metrics to determine if Neogen is a good buy. For example, gross profit margin measures Neogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Neogen's profitability and make more informed investment decisions.
Basic technical analysis of Neogen Stock
As of the 8th of December, Neogen secures the Downside Deviation of 3.65, risk adjusted performance of 0.0356, and Mean Deviation of 2.54. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neogen, as well as the relationship between them. Please verify Neogen treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Neogen is priced some-what accurately, providing market reflects its recent price of 5.98 per share. Given that Neogen has jensen alpha of 0.1286, we recommend you to check Neogen's last-minute market performance to make sure the company can sustain itself at a future point.Neogen's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neogen's Outstanding Corporate Bonds
Neogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Neogen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Neogen bonds can be classified according to their maturity, which is the date when Neogen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| TNEMAK 3625 28 JUN 31 Corp BondUS64045DAC83 | View | |
| US64049MAB63 Corp BondUS64049MAB63 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Neogen's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Neogen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0356 | |||
| Market Risk Adjusted Performance | 0.8023 | |||
| Mean Deviation | 2.54 | |||
| Semi Deviation | 3.4 | |||
| Downside Deviation | 3.65 | |||
| Coefficient Of Variation | 2514.45 | |||
| Standard Deviation | 3.79 | |||
| Variance | 14.38 | |||
| Information Ratio | 0.0191 | |||
| Jensen Alpha | 0.1286 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0198 | |||
| Treynor Ratio | 0.7923 | |||
| Maximum Drawdown | 27.41 | |||
| Value At Risk | (5.91) | |||
| Potential Upside | 5.73 | |||
| Downside Variance | 13.3 | |||
| Semi Variance | 11.54 | |||
| Expected Short fall | (2.81) | |||
| Skewness | 0.7572 | |||
| Kurtosis | 5.3 |
| Risk Adjusted Performance | 0.0356 | |||
| Market Risk Adjusted Performance | 0.8023 | |||
| Mean Deviation | 2.54 | |||
| Semi Deviation | 3.4 | |||
| Downside Deviation | 3.65 | |||
| Coefficient Of Variation | 2514.45 | |||
| Standard Deviation | 3.79 | |||
| Variance | 14.38 | |||
| Information Ratio | 0.0191 | |||
| Jensen Alpha | 0.1286 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0198 | |||
| Treynor Ratio | 0.7923 | |||
| Maximum Drawdown | 27.41 | |||
| Value At Risk | (5.91) | |||
| Potential Upside | 5.73 | |||
| Downside Variance | 13.3 | |||
| Semi Variance | 11.54 | |||
| Expected Short fall | (2.81) | |||
| Skewness | 0.7572 | |||
| Kurtosis | 5.3 |
Consider Neogen's intraday indicators
Neogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Neogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Neogen time-series forecasting models is one of many Neogen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Neogen Stock media impact
There is far too much social signal, news, headlines, and media speculation about Neogen that are available to investors today. This information is accessible both publicly - through Neogen's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neogen-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neogen alpha.
Neogen Corporate Management
| Dr MBA | Chief Officer | Profile | |
| Jeremy Yarwood | Chief Officer | Profile | |
| David Naemura | Executive Officer | Profile | |
| Bill Waelke | Head Relations | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Neogen's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.